GUANGZHOU ANYA MEDICAL SKINCARE PRODUCTS R&D CO., LTD – Trademark Portfolio
Entity Type: 16
GUANGZHOU ANYA MEDICAL SKINCARE PRODUCTS R&D CO., LTD holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include HINKICHER. The owner is based in GUANGZHOU.
ROOM 1605, NO. 238 GUANGYUN ROAD
BAIYUN DISTRICT
GUANGZHOU 510000 , CN
Showing of trademarks Trademarks
Trademark Classifications
GUANGZHOU ANYA MEDICAL SKINCARE PRODUCTS R&D CO., LTD's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does GUANGZHOU ANYA MEDICAL SKINCARE PRODUCTS R&D CO., LTD have?
GUANGZHOU ANYA MEDICAL SKINCARE PRODUCTS R&D CO., LTD has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does GUANGZHOU ANYA MEDICAL SKINCARE PRODUCTS R&D CO., LTD file in?
GUANGZHOU ANYA MEDICAL SKINCARE PRODUCTS R&D CO., LTD files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are GUANGZHOU ANYA MEDICAL SKINCARE PRODUCTS R&D CO., LTD's most well-known trademarks?
GUANGZHOU ANYA MEDICAL SKINCARE PRODUCTS R&D CO., LTD's registered trademark portfolio includes well-known marks such as HINKICHER. These are among 1 currently registered trademark in the portfolio.
What is GUANGZHOU ANYA MEDICAL SKINCARE PRODUCTS R&D CO., LTD's trademark registration success rate?
GUANGZHOU ANYA MEDICAL SKINCARE PRODUCTS R&D CO., LTD has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.